TrialBreast (Edinburgh, Scotland)2026

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

Mark Opdam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.